References
- Verma V, Parashar S, Lata K, Gaur P, Kaushik R, Sharma V. Pattern of treatment approaches for preeclampsia during pregnancy. Journal of Applied Pharmaceutical Sciences and Research. 2024;7(2):10–14. doi: 10.31069/japsr.v7i2.02
- Mitranovici MI, Chiorean DM, Moraru R, et al. Understanding the Pathophysiology of Preeclampsia: Exploring the Role of Antiphospholipid Antibodies and Future Directions. J Clin Med. 2024 May 2;13(9):2668. doi: 10.3390/jcm13092668
- Mitranovici MI, Chiorean DM, Oală IE, Petre I, Cotoi OS. Evaluation of the Obstetric Patient: Pregnancy Outcomes during COVID-19 Pandemic—A Single-Center Retrospective Study in Romania. Reports. 2022;5(3):27. doi: 10.3390/reports5030027
- Khan DSA, Hamid LR, Ali A, Salam RA, Zuberi N, Lassi ZS, Das JK. Differences in pregnancy and perinatal outcomes among symptomatic versus asymptomatic COVID-19-infected pregnant women: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2021 Dec 1;21(1):801. doi: 10.1186/s12884-021-04250-1
- Garovic VD, Dechend R, Easterling T, et al; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease, Kidney in Heart Disease Science Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 Feb;79(2):e21–e41. doi: 10.1161/HYP.0000000000000208
- Binder NK, MacDonald TM, Beard SA, et al. Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia. J Clin Med. 2021 Jul 30;10(15):3384. doi: 10.3390/jcm10153384.
- Anand S. Antihypertensive in Pregnancy-Pharmacotherapy Options. Biomedical and Pharmacology Journal. 2015;7(1):289–294. doi: 10.13005/bpj/490
- Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita ATN. Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines. Curr Hypertens Rep. 2020 Aug 27;22(9):66. doi: 10.1007/s11906-020-01082-w
- Mitranovici MI, Pușcașiu L, Oală IE, et al. A Race against the Clock: A Case Report and Literature Review Concerning the Importance of ADAMTS13 Testing in Diagnosis and Management of Thrombotic Thrombocytopenic Purpura during Pregnancy. Diagnostics (Basel). 2022 Jun 27;12(7):1559. doi: 10.3390/diagnostics12071559
- Leonard SA, Siadat S, Main EK, et al. Chronic Hypertension During Pregnancy: Prevalence and Treatment in the United States, 2008–2021. Hypertension. 2024 Aug;81(8):1716–1723. doi: 10.1161/HYPERTENSIONAHA.124.22731
- Yakoob MY, Bateman BT, Ho E, et al. The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis. Hypertension. 2013 Aug;62(2):375–381. doi: 10.1161/HYPERTENSIONAHA.111.00833
- Bozdağ H, Öğütcüoğlu FB, Duran EA, et al. The frequency and fetomaternal outcomes of early-and late-onset preeclampsia: The experience of a single tertiary health center in the bustling metropolis of Turkey; Istanbul. Medeniyet Medical Journal. 2015;30(4):163–169. doi: 10.5222/MMJ.2015.163
- Gryglas P, Jedrusik P, Wojciechowska E, et al. [PP.24.01] Serial ambulatory blood pressure monitoring, intensity of antihypertensive drug treatment, and pregnancy outcomes in women with hypertension found early during pregnancy. Journal of Hypertension. 2016;34:p e261. doi: 10.1097/01.hjh.0000492094.66024.ce
- Das SR, Bhusanpanigrahi B, Pani MK. Metoprolol succinate as selective drugs for treatment of hypertension in pregnancyas bi layer floating tablet: a review. International Journal of Pharmaceutical Research. 2019;11(4):673. doi: 10.31838/ijpr/2019.11.04.025
- Ghafarzadeh M, Shakarami A, Yari F, Namdari P. The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension. Hypertens Pregnancy. 2020 Aug;39(3):314–318. doi: 10.1080/10641955.2020.1766489
- Redman CW. Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis. 1991 Feb;17(2):149–53. doi: 10.1016/s0272-6386(12)81120-6
- Kubota K, Inai K, Shimada E, Shinohara T. α/β- and β-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age. Circ J. 2023 Mar 24;87(4):569–577. doi: 10.1253/circj.CJ-22-0647
- Akgün Aktaş B, Uzuner PF, Tanacan A, Sahin D. Obstetrics and fetal outcomes in pregnant women with beta-blocker treatment in maternal arrhythmia. JGON. 2024;21(1):8–12. doi: 10.38136/jgon.1275121
- Kayser A, Beck E, Hoeltzenbein M, et al. Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups. J Hypertens. 2020 Feb;38(2):354–361. doi: 10.1097/HJH.0000000000002256
- Sandström B. Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Invest. 1978;9(4):195–204. doi: 10.1159/000300984
- Katsi V, Papakonstantinou IP, Papazachou O, Makris T, Tsioufis K. Beta-Blockers in Pregnancy: Clinical Update. Curr Hypertens Rep. 2023 Feb;25(2):13–24. doi: 10.1007/s11906-023-01234-8
- Wang Y, Liu C, He X, Li Y, Zou Y. Effects of metoprolol, methyldopa, and nifedipine on endothelial progenitor cells in patients with gestational hypertension and preeclampsia. Clin Exp Pharmacol Physiol. 2019 Apr;46(4):302–312. doi: 10.1111/1440-1681.13063
- Vázquez-Rodríguez JG, Sánchez-Pardo CI. Postpartum Arterial Hypertension Management in Patients with Severe Preeclampsia. The Experience of a High Specialty Hospital of Mexico City. Journal of Advances in Medicine and Medical Research. 2022;34(23):111–121. doi: 10.9734/jammr/2022/v34i234844
- Miller J, Mishra S, Jena S, et al. Pregnancy induced hypertension & pre eclampsia: Pathophysiology & recent management trends: A review. IJPRAS. 2016;5(3):326–334.
- Pankiewicz K, Szczerba E, Fijałkowska A, Sierdziński J, Issat T, Maciejewski TM. The Impact of Coexisting Gestational Diabetes Mellitus on the Course of Preeclampsia. J Clin Med. 2022 Oct 28;11(21):6390. doi: 10.3390/jcm11216390
- Haas DM. Pharmacogenetics and individualizing drug treatment during pregnancy. Pharmacogenomics. 2014 Jan;15(1):69–78. doi: 10.2217/pgs.13.228
- Iannaccone A, Reisch B, Kimmig R, et al. Therapeutic Plasma Exchange in Early-Onset Preeclampsia: A 7-Year Monocentric Experience. J Clin Med. 2023 Jun 26;12(13):4289. doi: 10.3390/jcm12134289
- Attar A, Hosseinpour A, Moghadami M. The impact of antihypertensive treatment of mild to moderate hypertension during pregnancy on maternal and neonatal outcomes: An updated meta-analysis of randomized controlled trials. Clin Cardiol. 2023 May;46(5):467–476. doi: 10.1002/clc.24013
- Cox AG, Marshall SA, Palmer KR, Wallace EM. Current and emerging pharmacotherapy for emergency management of preeclampsia. Expert Opin Pharmacother. 2019 Apr;20(6):701–712. doi: 10.1080/14656566.2019.1570134
- Cavallasca JA, Costa CA, Maliandi MDR, Musuruana JL. Hot topics in lupus pregnancy. World J Rheumatol. 2013;3(3):32–39. doi: 10.5499/wjr.v3.i3.32
- Mitranovici M-I, Chiorean DM, Mureșan MC, et al. Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature. Stresses. 2023;3(1):125–135. doi : 10.3390/stresses3010010
- Editors. Hypertension Editors' Picks: Preeclampsia, Pregnancy, and Hypertension. Hypertension. 2018 Jul;72(1):e1–e18. doi: 10.1161/HYPERTENSIONAHA.118.11037
- Saleh L, Verdonk K, Jan Danser AH, et al. The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort. Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:121–6. doi: 10.1016/j.ejogrb.2016.02.013
- Chiorean DM, Cobankent Aytekin E, Mitranovici MI, et al. Human Placenta and Evolving Insights into Pathological Changes of Preeclampsia: A Comprehensive Review of the Last Decade. Fetal Pediatr Pathol. 2024 Jan–Feb;43(1):33–46. doi: 10.1080/15513815.2023.2274823
- Wang X, Guan M, Zhang X, et al. The Association Between S100A8/A9 and the Development of Very Late Stent Thrombosis in Patients With Acute Myocardial Infarction. Clin Appl Thromb Hemost. 2020;26:1076029620943295. doi: 10.1177/1076029620943295